Possible targets to treat myeloma-related osteoclastogenesis

Expert Review of Hematology
Marina BolzoniNicola Giuliani

Abstract

Bone destruction is the hallmark of multiple myeloma (MM). About 80% of MM patients at diagnosis presents myeloma bone disease (MBD) leading to bone pain and pathological fractures, significantly affecting patients' quality of life. Bisphosphonates are the treatment of choice for MBD, but osteolytic lesions remain a critical issue in the current management of MM patients. Several studies clarified the mechanisms involved in MM-induced osteoclast formation and activation, leading to the identification of new possible targets and the development of better bone-directed therapies, that are discussed in this review. Areas covered: This review summarizes the latest advances in the knowledge of the pathophysiology of the osteoclast formation and activation induced by MM cells, and the new therapeutic targets identified. Recently, neutralizing antibodies (i.e. denosumab, siltuximab, daratumumab), as well as recombinant fusion proteins, and receptor molecular inhibitors, have been developed to block these targets. Clinical trials testing their anti-MBD potential are ongoing. The emerging role of exosomes and microRNAs in the regulation of osteoclast differentiation has been also discussed. Expert commentary: Although further studies ar...Continue Reading

References

Jan 28, 1999·Biochemical and Biophysical Research Communications·B A SchevenS P Robins
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·R N PearseY Choi
Nov 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G David Roodman
Jan 17, 2003·Mayo Clinic Proceedings·Robert A KylePhilip R Greipp
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hideki KitauraSteven L Teitelbaum
Jun 7, 2005·Biochemical and Biophysical Research Communications·Ivana ZavrskiOrhan Sezer
Nov 14, 2006·Bone·Masataka Asagiri, Hiroshi Takayanagi
Dec 1, 2006·Journal of Leukocyte Biology·Loems Ziegler-Heitbrock
May 2, 2007·Journal of Cellular Biochemistry·T Sugatani, K A Hruska
Jun 5, 2007·Biochemical and Biophysical Research Communications·Ann T PoblenzBryant G Darnay
Feb 19, 2008·The Journal of Biological Chemistry·Seoung Hoon LeeYongwon Choi
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Nov 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Paul J KostenuikJohn K Sullivan
Nov 29, 2008·Leukemia·G D Roodman
Dec 4, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jon RuckleMatthew L Sherman
Dec 9, 2008·The Journal of Biological Chemistry·Toshifumi Sugatani, Keith A Hruska
Oct 15, 2009·The Journal of Biological Chemistry·Pasquale FasanaroFabio Martelli
Jan 28, 2010·Arthritis Research & Therapy·Yahui Grace ChiuChristopher T Ritchlin
Mar 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sonia ValletNoopur Raje
Mar 17, 2010·British Journal of Haematology·Shmuel Yaccoby
Nov 4, 2010·The Journal of Biological Chemistry·Soken TsuchiyaGozoh Tsujimoto
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H HenryHoward Yeh
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Aug 13, 2011·Biomaterials·Omar M OmarPeter Thomsen
Nov 29, 2011·Apoptosis : an International Journal on Programmed Cell Death·Ji FangLi Lin

❮ Previous
Next ❯

Citations

Dec 14, 2018·International Journal of Molecular Sciences·Hanley N Abramson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Bone and Mineral Metabolism
G David Roodman
Expert Review of Hematology
Maria GavriatopoulouE Terpos
Expert Opinion on Pharmacotherapy
Claire M ShipmanGregory R Mundy
Metabolism: Clinical and Experimental
E TerposMaria Gavriatopoulou
© 2022 Meta ULC. All rights reserved